BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35736382)

  • 1. [Hyperkalemia due to low-molecular-weight heparin].
    van der Heiden W; Koopman JJEB; Appelman-Dijkstra NM; den Exter PL
    Ned Tijdschr Geneeskd; 2022 Jun; 166():. PubMed ID: 35736382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin.
    Hottelart C; Achard JM; Moriniere P; Zoghbi F; Dieval J; Fournier A
    Artif Organs; 1998 Jul; 22(7):614-7. PubMed ID: 9684701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.
    Gheno G; Cinetto L; Savarino C; Vellar S; Carraro M; Randon M
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):373-7. PubMed ID: 12851802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced hyperkalemia.
    Thomas CM; Thomas J; Smeeton F; Leatherdale BA
    Diabetes Res Clin Pract; 2008 May; 80(2):e7-8. PubMed ID: 18343525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced hyperkalemia.
    Aull L; Chao H; Coy K
    DICP; 1990 Mar; 24(3):244-6. PubMed ID: 2180218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced hyperkalemia confirmed by drug rechallenge.
    Orlando MP; Dillon ME; O'Dell MW
    Am J Phys Med Rehabil; 2000; 79(1):93-6. PubMed ID: 10678609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.
    Melzer N; Bramlage P; Michaelis HC
    BMC Res Notes; 2014 Dec; 7():880. PubMed ID: 25480344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels.
    Rocha E; Gómez-Outes A; Martínez González J; Kakkar VV
    Thromb Haemost; 2005 Nov; 94(5):1109-10. PubMed ID: 16363259
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review.
    Amdetsion GY; Gudeta A; Lumley G; Sagoo H; Aliledhin E
    EJHaem; 2023 Nov; 4(4):1110-1116. PubMed ID: 38024642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludrocortisone for the treatment of heparin-induced hyperkalemia.
    Sherman DS; Kass CL; Fish DN
    Ann Pharmacother; 2000 May; 34(5):606-10. PubMed ID: 10852087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced hyperkalaemia - a case report].
    Knysak M; Smyk Ł; Stompór T
    Pol Merkur Lekarski; 2018 Oct; 45(268):158-160. PubMed ID: 30371650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: acknowledging its presence in low-molecular weight heparin therapy.
    Ng HJ; Lee LH
    Int J Hematol; 2003 Feb; 77(2):185-7. PubMed ID: 12627856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced hyperkalemia in a patient diagnosed with thyroid storm.
    Cho R; Leclaire M; Kempainen R
    Ann Pharmacother; 2013 Sep; 47(9):1213-7. PubMed ID: 24259739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia.
    Kovacs J; Talib S; Khashan A; Garsondiya B; Carson MP
    Am J Case Rep; 2022 Jul; 23():e937017. PubMed ID: 35859349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium.
    Mitić G; Kovac M; Povazan L; Djordjević V; Ilić V; Salatić I; Lazić R; Antonijević N; Novakov-Mikić A
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():18-22. PubMed ID: 20229677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced hyperkalemia in an extremely-low-birth-weight infant: a case report.
    Shimokaze T; Akaba K; Saito E
    J Clin Res Pediatr Endocrinol; 2014; 6(2):125-8. PubMed ID: 24932609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study.
    Dluha J; Sivak S; Kurca E; Dusenka R; Kalmarova K; Turcanova Koprusakova M; Kantorova E; Nosal V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):543-548. PubMed ID: 27646496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.